Navigation Links
IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
Date:4/11/2008

Devices

Peronnas -- France Small Bone Innovations Devices

Galway, Ireland Proxy Biomedical Devices

Limited

London, England CYTOX Limited Diagnostics

Tokyo, Japan Glycosience Biopharmaceuticals

Laboratories

Goias, Brazil Scitech Produtos Devices

Medicos Ltda.

Tennessee, USA Asklepion Biopharmaceuticals

Pharmaceuticals

Allschwill, Evolva SA Biopharmaceuticals

Switzerland

Belo Horizonte, Alvos Biotec Biopharmaceuticals

Brazil

Yokneam, Israel Navotek Medical Ltd. Devices

Ohio, USA m2m Imaging Corp. Devices

You may view company abstracts by visiting http://www.globalhealthcareinvesting.com

This year's conference sponsors have raised the bar on helping secure speakers and presenting companies. 2008's sponsors include: Squire Sanders & Dempsey, LLP; Musculoskeletal Clinical Regulatory Advisers, LLC; UK Trade & Investment; and National City. To learn more about the event and to register, please visit http://www.globalhealthcareinvesting.com.

About BioEnterprise

BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to health care companies. BioEnterprise's partners are Case Western Reserve University, the Cleveland Clinic, University Hospitals, and Summa Health System. Additional technology partners include the NASA Glenn Research Center,
'/>"/>

SOURCE IBF Conferences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
2. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
3. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
4. Oncothyreon to present at upcoming investment conferences
5. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
6. BD to Present at Investor Healthcare Conferences
7. IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
8. Micromet to Present at Two Upcoming Investor Conferences
9. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Monsanto Executives to Address Investor Conferences in February
11. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Spartan Bioscience announced today that Health Canada ... It detects CYP2C19 genetic mutations in less than 60 ... RX CYP2C19 System is the first near-patient DNA test ... Due to the system’s ease of use, Health Canada ... professionals such as doctors, nurses, pharmacists, and laboratory technicians, ...
(Date:10/30/2014)... A new report, commissioned by BioCrossroads and conducted by ... at Indiana,s capital market and ... time frames: 1993 to 2002 and 2003 to 2013.  ... investment growth.  The Life Science Innovation Capital in ... innovation dollars as well as an increase in life ...
(Date:10/27/2014)... (PRWEB) October 27, 2014 The ... by Type (High & Medium), Sub-type (Primary & ... Processing, Infrastructure & Transportation & Power Generation) - ... the GIS market with analysis and forecasting of ... Market Data Tables with 52 Figures spread through ...
(Date:10/27/2014)... (PRWEB) October 27, 2014 New ... SoundConnect , an industry leading unified communication ... partners and agents to deliver cloud-based audio and ... growth opportunities. , With SoundConnect’s Q4 incentive ... twenty-five video and/or web conferencing licenses sold, now ...
Breaking Biology Technology:Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 2New report shows Indiana's gains in life sciences innovation capital outpace the nation 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 4New report shows Indiana's gains in life sciences innovation capital outpace the nation 5Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4SoundConnect Unveils Q4 Partner Incentives 2
... Data and User Customization -- BUDAPEST, Hungary, August 20, 2010 ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... Confirms Clinical Efficacy and Safety of Radioembolisation Using... -- BRUSSELS, August 19, 2010 ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
... Silence Therapeutics plc (AIM: SLN), a leading international RNAi ... Quark Pharmaceuticals, Inc. ("Quark"), has announced the grant of ... license to develop and commercialise QPI-1002, a p53 temporary ... Quark is currently conducting a Phase II clinical ...
Cached Biology Technology:ChemAxon Extends chemicalize.org Free Service With Predicted Data and User Customization 2ChemAxon Extends chemicalize.org Free Service With Predicted Data and User Customization 3ChemAxon Extends chemicalize.org Free Service With Predicted Data and User Customization 4ChemAxon Extends chemicalize.org Free Service With Predicted Data and User Customization 5ChemAxon Extends chemicalize.org Free Service With Predicted Data and User Customization 6Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy 2Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy 3Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy 4Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy 5Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy 6Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy 7Silence Therapeutics' Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002 2
(Date:10/30/2014)... suite of technologies that can be used to enhance ... everything from search and rescue to service dogs to ... computer-mediated communication between humans and dogs that opens the ... and sending them clear and unambiguous cues in return," ... science at NC State and co-lead author of a ...
(Date:10/29/2014)... Research suggesting air pollutants released by unconventional oil and ... US is published today in the open access journal ... sulfide and formaldehyde were found. The study is the ... who live near production sites and could be used ... and gas come from reserves that do not readily ...
(Date:10/29/2014)... (October 29, 2014, Beaverton, OR) New research ... 11th International Conference in Houston, TX showed for ... eliminate HPV infection in women using a readily ... The study, presented by Dr. Judith A. Smith, ... Gynecology and Reproductive Sciences at The University of ...
Breaking Biology News(10 mins):New tech aims to improve communication between dogs and humans 2Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
... of Parkinson,s disease patients had insufficient levels of vitamin ... of Medicine. The fraction of Parkinson,s patients ... than patients with Alzheimer,s disease (41 percent) or healthy ... in the October issue of Archives of Neurology ...
... of their chimpanzee relatives, bonobo societyin which females enjoy ... of image. While chimpanzee males frequently band together to ... believed to restrict what meat they do eat to ... according to a study, reported in the October 14th ...
... of the brain can come under attack in patients with ... with an MS-like disease, the brain,s response to a protein ... cord or cerebellum that comes under fire. The studyfrom researchers ... and Washington University in St. Louiswill be published online on ...
Cached Biology News:Lack of vitamin D linked to Parkinson's disease 2Lack of vitamin D linked to Parkinson's disease 3Despite 'peacenik' reputation, bonobos hunt and eat other primates too 2
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... been developed for use with immunohistochemical ... nonspecific background staining due to endogenous ... peroxidase with hydrogen peroxide. This ... with additional novel components to further ...
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544...
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: